Home / 2015 / January (page 7)

Monthly Archives: January 2015

Beloranib Demonstrates Weight Loss in Hypothalamic Injury-Associated Obesity

The drug, a first-in-class MetAP2 inhibitor, was well-tolerated and also improved cardiovascular disease risk factors… Zafgen has announced that ZAF-221, a randomized, double-blind, placebo-controlled Phase 2 clinical trial of beloranib, a MetAP2 inhibitor, in 14 adults with hypothalamic injury associated obesity, or HIAO, met the primary efficacy endpoint of weight …

Read More »

Type 2 Diabetes Increased Risk for Colorectal Cancer

Dutch researchers evaluated data on 300,039 type 2 adults on at least one prescription for an antidiabetes drug, and a comparison cohort without diabetes (controls) to determine the relationship between type 2 diabetes and colorectal cancer. “We observed a moderate, yet (1.3-fold) significantly increased, risk of colorectal cancer in patients …

Read More »

Women with PTSD Have Higher Risk for Type 2 Diabetes

In this 22-year study of women, symptoms of post-traumatic stress disorder (PTSD) were associated with the incidence of type 2 diabetes in a dose-dependent manner. The authors conclude that women with PTSD were at a twofold increased risk for having type 2 diabetes than counterparts without PTSD, and thus care …

Read More »

Patient Handout – A Diabetes Glossary

When a patient is diagnosed with diabetes the first thing they will most likely do is go to the internet. This glossary, courtesy of dLife, will provide them the definitions for most of the medical terms they will see and make them more aware of their situation. Plus it will …

Read More »

FDA Approves VBLOC Vagal Blocking Therapy for Weight Loss

VBLOC Therapy is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. Therapy is delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by blocking the primary nerve which regulates …

Read More »

t:flex Insulin Pump Cleared by FDA

  The t:flex Pump is designed for patients who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes. The pump offers the benefits of pump therapy without the frequent reservoir changes required by 200- and …

Read More »

Letter from the Editor, #764

This was a particularly aggravating week for both my patients and insurance companies. The new year has brought copays and deductibles to many of my Part D patients. Most of them had no idea that they now had a $200 deductible and swore that their plan did not tell them …

Read More »